• 25TH NOVEMBER 2022

    November 2022 Price Concessions 3rd Update

    The Department of Health and Social Care (DHSC) has today (25/11/2022) granted the following list of price concessions for November 2022: Drug Pack size Price concession Amoxicillin 500mg capsules 15 £1.85 Amoxicillin 500mg capsules 21 £2.59 Omeprazole 20mg gastro-resistant capsules 28 £2.60 Prednisolone 5mg soluble tablets 30 £62.00 Pregabalin 25mg capsules 56 £1.69 The DHSC

    Read more
    • 25TH NOVEMBER 2022

    NHSmail changes: keeping your account active

    To increase the security of the NHSmail system, the NHSmail team will shortly be making changes to the system that will impact users. From 1st December 2022, personal NHSmail accounts which are not used for 30 days will be marked inactive and inactive accounts which are not activated within the following 30 days will be

    Read more
    • 25TH NOVEMBER 2022

    Medicine Supply Notification: Atorvastatin (Lipitor® ) 20mg chewable tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Atorvastatin (Lipitor®) 20mg chewable tablets. MSN/2022/098 Tier 2 – medium impact Date of issue 24th November 2022 Atorvastatin (Lipitor®) 20mg chewable tablets are out of stock until late December 2022. Atorvastatin 20mg film-coated tablets and atorvastatin 20mg/5ml oral suspension remain available

    Read more
    • 23RD NOVEMBER 2022

    New SSP issued for Lipitor® 20mg chewable tablets

    In response to a significant ongoing disruption to the supply of Lipitor® 20mg chewable tablets , a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today, 23 November 2022, SSP039 provides that for every Lipitor® 20mg chewable tablet originally prescribed, either one Atorvastatin 20mg tablet or the equivalent

    Read more
    • 23RD NOVEMBER 2022

    Contractor Notice: Expiry of SSP037 Estraderm MX® 50mcg patches

    The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Estraderm MX® 50mcg patches are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP037 Estraderm MX® 50mcg patches expires at 23.59pm on Wednesday 23 November 2022. After this date, any prescriptions for Estraderm MX® 50mcg

    Read more
    • 23RD NOVEMBER 2022

    Reminder: Completing patient declarations for age exempt patients

    PSNC’s Pricing Audit Team have noted seeing an increase in unsigned patient declarations for patients who are age exempt where the date of birth is handwritten. Pharmacy teams are reminded that where the date of birth is handwritten the patient declaration on the reverse of the prescription MUST be completed in full, i.e. exemption box

    Read more
    • 22ND NOVEMBER 2022

    PQS: Assessment framework now available

    Community pharmacy contractors can now access the assessment framework on PharmOutcomes for the 2022/23 Pharmacy Quality Scheme (PQS). This is available free of charge to all contractors. The assessment framework allows contractors and their teams to track their progress with achieving the gateway and quality criteria/domains of the PQS. Once a contractor has logged into PharmOutcomes,

    Read more
    • 22ND NOVEMBER 2022

    November 2022 Price Concessions 2nd Update

    The Department of Health and Social Care (DHSC) has today (22/11/2022) granted the following list of price concessions for November 2022: Drug Pack size Price concession Alendronic acid 70mg tablets 4 £5.36 Amisulpride 100mg tablets 60 £20.29 Amisulpride 200mg tablets 60 £33.92 Amisulpride 50mg tablets 60 £13.09 Amorolfine 5% medicated nail lacquer 5 £7.34 Aripiprazole

    Read more
    • 21ST NOVEMBER 2022

    Help improve the Electronic Prescription Service

    NHS Digital is asking community pharmacy team members to share their experience of using the Electronic Prescription Service (EPS) by volunteering to take part with a short EPS interview. Such user feedback is essential to informing the future development of the system ahead of the planned launch of the next generation of EPS. PSNC and

    Read more
    • 21ST NOVEMBER 2022

    MHRA – Class 4 Medicines Defect Information: Hyoscine Butylbromide 20 mg film-coated tablets (Morningside Healthcare Limited)

    Class 4 Medicines Defect Information: Hyoscine Butylbromide 20 mg film-coated tablets (Morningside Healthcare Limited) Drug alert number: EL (22)A/48 Date issued: 21 November 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Hyoscine Butylbromide 20 mg film-coated tablets, PL 20117/0349 Batch Number Expiry Date Pack

    Read more